JP2024528351A5 - - Google Patents

Info

Publication number
JP2024528351A5
JP2024528351A5 JP2023522408A JP2023522408A JP2024528351A5 JP 2024528351 A5 JP2024528351 A5 JP 2024528351A5 JP 2023522408 A JP2023522408 A JP 2023522408A JP 2023522408 A JP2023522408 A JP 2023522408A JP 2024528351 A5 JP2024528351 A5 JP 2024528351A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
amino acid
protein
fam19a5
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023522408A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024528351A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/056357 external-priority patent/WO2023281475A1/en
Publication of JP2024528351A publication Critical patent/JP2024528351A/ja
Publication of JP2024528351A5 publication Critical patent/JP2024528351A5/ja
Pending legal-status Critical Current

Links

JP2023522408A 2021-07-08 2022-07-08 ポリペプチド抑制剤及びその用途 Pending JP2024528351A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163219670P 2021-07-08 2021-07-08
US63/219,670 2021-07-08
PCT/IB2022/056357 WO2023281475A1 (en) 2021-07-08 2022-07-08 Polypeptide inhibitors and uses thereof

Publications (2)

Publication Number Publication Date
JP2024528351A JP2024528351A (ja) 2024-07-30
JP2024528351A5 true JP2024528351A5 (https=) 2025-07-16

Family

ID=84801485

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023522408A Pending JP2024528351A (ja) 2021-07-08 2022-07-08 ポリペプチド抑制剤及びその用途

Country Status (6)

Country Link
US (1) US20250333441A1 (https=)
EP (1) EP4367128A4 (https=)
JP (1) JP2024528351A (https=)
KR (1) KR20240034159A (https=)
CN (1) CN117881687A (https=)
WO (1) WO2023281475A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005508145A (ja) * 2001-06-15 2005-03-31 インサイト・ゲノミックス・インコーポレイテッド 細胞成長、分化および細胞死関連タンパク質
CN104254343A (zh) * 2012-02-15 2014-12-31 高丽大学校产学协力团 参与调节胶质细胞生成的fam19a5的医药用途
WO2019207513A1 (en) * 2018-04-24 2019-10-31 Neuracle Science Co., Ltd. Use of anti-family with sequence similarity 19, member a5 antibodies for the treatment of neuropathic pain
CN113195533B (zh) * 2019-01-02 2024-04-26 纽洛可科学有限公司 抗序列相似家族19成员a5的抗体及其使用方法

Similar Documents

Publication Publication Date Title
Li et al. Cloning, expression, isotope labeling, and purification of human antimicrobial peptide LL-37 in Escherichia coli for NMR studies
RU2385161C2 (ru) Способ лечения болезни альцгеймера
US5888762A (en) Neurotropic growth factors comprising a homeobox peptide
JP2020508666A5 (https=)
JP2020503262A5 (ja) アクチビンＩＩａ型受容体変異体および同変異体を含む医薬組成物
AT506535A1 (de) Mimotope
JP2010524958A5 (https=)
CN112040969B (zh) 用于化妆品和医药的肽和组合物
CN105658228B (zh) 结合人类补体c5的稳定多肽
JP2023528207A5 (https=)
CN102190708B (zh) 一种桶形α芋螺多肽Bt1.3及其应用
JP2020518249A5 (https=)
JP2010509209A (ja) 新規なω−コノトキシン
JP2025120320A (ja) Ｖｉｐｒ２アンタゴニストペプチド
HUP0500637A2 (hu) Neublasztin polimer konjugátumai és alkalmazási eljárásai
WO2020238692A1 (zh) αO-芋螺毒素肽GeXIVA新突变体、其药物组合物及用途
JP2024528351A5 (https=)
JP2005511015A5 (https=)
WO2004113535A1 (ja) 凝集抑制作用を有するシヌクレイン変異体
WO2024115492A1 (en) Peptides capable of inhibiting protein-protein interactions at gabab1a subunit and uses thereof
CN113563427B (zh) 抗菌短肽lbd-s及其应用和药物
CN112457378B (zh) 具有广谱抗菌活性及低溶血性的temporin-1CEc改造肽
AU2018274569B2 (en) Voltage-Gated Calcium Channel auxilliary subunit alpha 2 delta and uses thereof
CN108084247B (zh) 一种合成多肽及其合成方法和应用
CN116554342A (zh) 一种融合表达Tau-4R蛋白的大肠杆菌工程菌株